Phase 1 Study of CART-ddBCMA, a CAR-T therapy utilizing a novel synthetic binding domain, for the treatment of subjects with relapsed and refractory multiple myeloma.

Bibliographic Details
Title: Phase 1 Study of CART-ddBCMA, a CAR-T therapy utilizing a novel synthetic binding domain, for the treatment of subjects with relapsed and refractory multiple myeloma.
Authors: Frigault, Matthew J., O'Donnell, Elizabeth, Raje, Noopur S., Cook, Daniella, Yee, Andrew, Rosenblatt, Jacalyn, Gibson, Chelsey, Logan, Emma, Avigan, David, Bishop, Michael Russell, Eckert, Katherine, Daley, Heather, Rodriguez, Diego Hernandez, Mason, Andrew, Nikiforow, Sarah, Mangus, Carissa, Gil-Krzewska, Aleksandra, Currence, Scott, Shen, Angela, Maus, Marcela Valderrama
Source: Journal of clinical oncology. 39(15 suppl):8015-8015
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173216855.0x000001&indx=1&recIds=ETOCvdc_100173216855.0x000001
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:0732183X
Published in:Journal of clinical oncology
Language:English